XERS Key Metrics | Stock Alarm Pro

Sign In Create Free Alerts

Xeris Biopharma Holdings, Inc.XERSNASDAQ

Loading

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Key Metrics

As of 2025• vs 2024

Core Metrics

Market Cap

$1.26B+153.1%

2,273.17+25152.6%

Interest Coverage

Per Share

Revenue/Share

$1.82+31.5%

Net Income/Share

$0.00+100.9%

Operating CF/Share

$0.18+170.8%

Free CF/Share

$0.17+167.5%

Cash/Share

$0.69+41.8%

Book Value/Share

$0.09+142.3%

Tangible Book/Share

$-0.61+41.2%

Equity/Share

$0.09+142.3%

Interest Debt/Share

$0.42-79.9%

Valuation

Market Cap

$1.26B+153.1%

Enterprise Value

$1.19B+70.1%

2,273.17+25152.6%

P/OCF Ratio

43.99+427.0%

P/FCF Ratio

45.09+443.0%

P/TB Ratio

92.00+647.6%

EV/EBITDA

93.32+287.3%

Profitability

Return on Tangible Assets

Capital Allocation

CapEx/OCF

2.43%+203.6%

CapEx/Revenue

0.24%-44.2%

CapEx/Depreciation

0.06-16.7%

SBC/Revenue

7.66%-15.3%

Balance Sheet

Net Debt/EBITDA

-5.77+59.6%

Interest Coverage

Efficiency

Days Sales Outstanding

64 days-12.1%

Days Payables Outstanding

21 days-7.4%

Days Inventory

469 days-1.7%

Receivables Turnover

5.72x+13.8%

Payables Turnover

17.36x+8.0%

Inventory Turnover

0.78x+1.7%

Special Valuations

Graham Number

$0.08

Graham Net-Net

$-1.16+24.9%

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance